Cannabis News
The End of the Hemp Industry? The DEA is Coming for Hemp-Derived Delta-8 THC, And Maybe More Synthetic Cannabinoids
Your Corporate Political Overlords discuss the finer details on how they own you
Did you hear?
The DEA recently released their new updated “slaver’s agreement,” where your bodily autonomy gets violated and labeled a “crime” – in which you forgo your liberty under the 12th Amendment and become property of the state.
Their latest update comes in retaliation to the market’s “loophole”, Delta-8 THC.
Allow me to summarize an article originally published in Marijuana Moment.
The Drug Enforcement Administration (DEA) is at it again, my fellow cannabis enthusiasts. According to recent reports, the DEA is preparing to propose new rules that would classify synthetically manufactured cannabinoids, such as delta-8 THC, as prohibited controlled substances. Oh, joy!
During the agency’s Supply Chain Conference, Terrance Boos, the chief of the DEA’s Drug and Chemical Evaluation Section, revealed their plans to modify regulations on cannabis constituents based on recommendations from the U.S. Department of Health and Human Services (HHS). One proposed change is to “decontrol CBD up to 0.1 percent THC.” In other words, they want to loosen the grip on CBD slightly, but don’t get too excited—it’s a minuscule step in the right direction.
The intention behind these new rules, they claim, is to provide clarity and eliminate confusion surrounding the legal status of various cannabinoids. Since the federal legalization of hemp and its derivatives under the 2018 Farm Bill, the market for cannabis products has exploded. However, the emergence of intoxicating cannabinoids like delta-8 THC has caused quite the stir, prompting lawmakers in various states to scramble and create a chaotic patchwork of regulations for these products.
Here’s the thing, my friends: delta-8 THC does occur naturally in cannabis in trace amounts, and the DEA had previously confirmed that these natural constituents were uncontrolled. But hold on to your hats because they’re about to drop the hammer. The DEA wants to crack down on “synthetic delta-8 THC”, which is produced through a chemical process that converts CBD into this delightful compound.
They argue that synthetic tetrahydrocannabinols, like delta-8 THC, are not exempted from the Controlled Substances Act (CSA), unlike their naturally produced counterparts.
Basically, they just closed the “loophole” with the legal Delta 8 issue.
Now, let’s take a moment to appreciate the sheer brilliance of this move. The DEA, in their infinite wisdom, wants to tighten their grip on a compound that can be obtained naturally from the plant but is suddenly deemed dangerous when synthesized in a lab. It’s almost as if they’re determined to make our lives as difficult as possible while completely disregarding the scientific evidence and the will of the people.
But we know that the Controlled Substance Act never utilized Science or Reason at its core. We know that the CSA is merely a tool of the oppressors
But fear not, my dear readers, for the battle is not lost. The final rule from the DEA is yet to be unveiled, and we must remain vigilant and united in our fight for cannabis freedom. Additionally, there are potential changes on the horizon with the next iteration of the farm bill and President Biden’s review of marijuana scheduling. These developments could shape the landscape of cannabis regulation and have a profound impact on the industry.
However, when it comes to Biden and his ilk – I wouldn’t hold my breath. In fact, those guys are trying to set it up so that Pharma can get main control over the cannabis industry. This is because irrespective of their party colors – they all serve the same masters.
In the midst of this regulatory frenzy, it’s crucial to stay informed and engaged. Companies and individuals must pay attention and actively participate in the discussions surrounding these issues.
The lack of regulatory guidance from the Food and Drug Administration (FDA) only adds to the confusion. The FDA has yet to establish clear rules for hemp-derived CBD products, leaving companies and consumers in a state of limbo.But then again, this isn’t surprising either.
The FDA has the power to reschedule cannabis and provide much-needed regulatory clarity. But alas, they claim they lack the authority to do so without congressional support. Meanwhile, the DEA, who holds the keys to the rescheduling kingdom, insists on relying on the FDA’s scientific review before making any moves. It’s a never-ending loop of finger-pointing and bureaucratic inertia, leaving us stuck in a limbo of uncertainty. Oh, the joys of government bureaucracy at its finest!
This is also by design. It’s not an accident that the FDA – which is primarily funded by Pharma – somehow can’t seem to get the “safety profile” of cannabis after decades and decades of research. But magically, almost as if they were paid billions – they could fast track a vaccine that was not effective at stopping transmissions and empirically didn’t perform that much better than natural immunity.
But I digress.
While we brace ourselves for the DEA’s final rule on synthetic cannabinoids, we must remember that enforcement resources are limited. The FDA is likely to focus on public safety concerns and legality, as demonstrated by their joint enforcement action in Minnesota. The ultimate decision rests with the DEA, and we can only hope they’ll come to their senses and acknowledge the absurdity of their current stance.
So, my friends, let us stand together in defiance of the DEA’s attempts to stifle our freedom and enjoyment of cannabis. We must remain informed, engaged, and vocal in our opposition to these draconian regulations.
But let’s dive deeper into how this will impact the cannabis industry, especially in states that don’t have cannabis laws on the books.
How this change will impact legal THC?
Well, in a nutshell, the DEA has given themselves the power to go out and bust up any sales of Delta-8 that “isn’t natural”. How they will prove this is still to be decided, but essentially, you can expect them to conduct raids or at the very least send out “cease and desist” letters to those establishments that are currently selling it.
But that is only talking about the legal establishments. The real victims here are the people who need access to cannabis in prohibition states.
You see, Delta-8 THC, a cannabinoid derived from hemp, has been providing a legal avenue for individuals, including veterans and those suffering from chronic pain, to access the therapeutic benefits of cannabis without running afoul of strict state laws. It was a glimmer of hope, a ray of light in the darkness of prohibition.
But alas, the DEA, in their insatiable need to remain relevant and flex their authority, has decided to crush that hope.
By classifying Delta-8 THC as illegal, they have effectively cut off the legal option for those who rely on its medicinal properties. Once again, individuals in prohibition states are forced to go underground, to seek out illicit sources for their cannabis needs. It’s a tragic cycle, my friends, one that perpetuates the black market and denies people access to safe, regulated products.
The DEA’s decision is particularly disheartening because it disregards the growing acceptance and tolerance of adult drug use in our society.
As more and more states embrace cannabis legalization, it seems the DEA is desperately clinging to the vestiges of a bygone era. Instead of adapting to the changing times and acknowledging the potential benefits of cannabis, they choose to stifle progress and maintain their grip on power.
In doing so, the DEA not only undermines the rights of individuals to make informed choices about their own well-being but also perpetuates the harms of the black market. It’s a lose-lose situation, my friends.
Those in need of cannabis for medical purposes are left without legal options, and the black market thrives once again, with all its associated dangers and risks.
So, we find ourselves in a familiar position, caught in the crossfire of outdated policies and misguided attempts to control what people choose to put in their bodies.
It’s a frustrating reality, but one that only strengthens our resolve to advocate for sensible drug policies and the rights of individuals to access the substances that can improve their quality of life.
My dear friends, the time has come for a new conversation, a conversation that challenges the outdated notions surrounding drugs, drug use, and individual autonomy. We must question the hypocrisy that exists in our society, where we are allowed to consume unhealthy processed foods and poison ourselves with high-fructose garbage, but somehow lack the intelligence to make informed decisions about other substances.
It’s time to recognize that agencies tasked with protecting us from ourselves are unnecessary and often hinder progress. We should have the right to determine what we put into our bodies, as long as we are aware of the risks and benefits involved. The freedom to make choices about our own well-being should extend to all areas of consumption, not just those deemed acceptable by societal norms.
Let us be outspoken about these issues, my friends. Let us challenge those who cling to archaic ideas and stand in the way of progress. It is time to evolve beyond the restrictive mindset of the 1900s and embrace a future where individual autonomy is cherished and respected.
Together, let us advocate for a society that values personal freedom, informed decision-making, and the right of individuals to determine what is best for their own bodies. Only through open dialogue and a commitment to change can we pave the way for a more enlightened and compassionate approach to drugs and human rights.
So, my friends, let us raise our voices, challenge the status quo, and forge a path towards a future where the rights of individuals are paramount. The time for change is now, and together, we can create a society that truly embraces individual autonomy as a sacred right.
MORE ON THE DEA OVER-REACH, READ ON…
THE DEA IS COMING FOR DELTA-8 THC, HHC, AND HEMP-DERIVED PRODUCTS!
Germany had a record 34.6 tons of cannabis imported in 2023 for medicinal and research uses, a significant increase from previous years. This inflow highlights how Europe’s biggest medical marijuana market—which is federally regulated—is changing, as seen by the increasing interest that foreign organizations are showing in Germany’s cannabis sector. Notwithstanding a little slowdown in growth relative to prior years, the notable rise in imports underscores the nation’s critical position in molding the world’s cannabis industry.
The surge in cannabis imports coincides with significant shifts in Germany’s regulatory framework, particularly the abolition of the previous cultivation quota system. This system, which restricted domestic cultivation to a select few companies, compelled the nation to heavily rely on imports to meet demand. With the introduction of more flexible conditions for cultivating medical cannabis under the new legislation, Germany aims to reduce its dependence on foreign imports, ushering in a potentially transformative era for the domestic cannabis industry.
End of Cultivation Quota System: A New Era for German Cannabis
The abolition of Germany’s growing quota system, which marks a watershed moment in the country’s cannabis industry, promises a paradigm shift in cultivation dynamics. Only three companies were awarded permits to develop medical marijuana under the previous system, following a stringent application process. As a result, their total output was limited to 10,400 kg over four years. As a result, the shortage of supplies from domestic farms forced a considerable reliance on imports to meet rising demand.
However, with the latest regulatory revision, enterprises may now apply directly to the Cannabis Agency for permission to produce medicinal marijuana. This decision marks a shift from the tight quotas of the past, providing a more streamlined and accessible route for firms to engage in cannabis growing. Peter Homberg, a major person in Germany’s cannabis business, believes that the increased flexibility in cultivation conditions will progressively reduce the need for foreign imports, opening the path for more self-sufficiency in the home market.
Once the growing quota system is removed, there will be a great deal of freedom for expansion and innovation in the German cannabis industry. By allowing a greater variety of companies to engage in cultivation, the regulation change fosters a more competitive environment that is advantageous to development and diversity. Moreover, this is a significant step toward aligning German cannabis regulations with evolving international standards, therefore enhancing the nation’s competitiveness in the global cannabis market.
While the transition away from import dependence may take time to materialize fully, the dismantling of the cultivation quota system sets the stage for a transformative journey towards self-sustainability. As companies seize the opportunity to expand their cultivation operations under the new regulatory framework, Germany inches closer to realizing its vision of a thriving and resilient domestic cannabis industry.
Imports in Flux: Dynamics of Germany’s Medical Cannabis Market
Germany is a significant importer of medicinal cannabis, but its position is under examination due to changing market dynamics and regulatory environments. In the past, the country has been a vital market for foreign exporters, providing profitable prospects in the largest federally regulated medicinal marijuana industry in Europe. Nonetheless, recent legislative modifications, such as the removal of marijuana from the list of illegal substances, portend a possible reorganization of Germany’s import market.
The elimination of the requirement for patients to get specific prescriptions for medicinal cannabis has simplified access to the drug by removing marijuana off Germany’s list of illegal substances. Standard prescriptions, on the other hand, are sufficient, streamlining the procedure and maybe stimulating demand in the medical cannabis industry. This legislative change is anticipated to rebalance the import-export dynamics, which might change the way cannabis goods enter Germany and change international export tactics.
It’s unclear how long Germany will continue to rely on cannabis imports despite these legislative changes. The timetable for reaching self-sufficiency is still unclear, even though it is expected that domestic cultivation and the elimination of regulatory obstacles would eventually lessen reliance. The future course of Germany’s medicinal cannabis market may be significantly influenced by strategic alliances and infrastructure investments made by industry players as they traverse this transitional period.
Fostering Domestic Growth: Germany’s Cannabis Cultivation Outlook
The cannabis industry is seeing a radical change as Germany allows for larger-scale commercial cultivation. The possibility of obtaining cultivation permits offers domestic businesses a special chance to profit from the growing market for medical marijuana. Demecan’s managing director, Constantin von der Groeben, is upbeat about the industry’s potential for expansion and notes that his company is prepared to surpass prior production quotas in light of the current legal environment. This shift toward homegrown production represents a calculated attempt to foster self-sufficiency in the German cannabis industry. Although imports would still be necessary to meet demand right away, the granting of crop licenses indicates a more extensive commitment to developing domestic production capacity. The sector prepares for a period of innovation and growth as stakeholders look at opportunities for extended cultivation activities.
This pivot towards domestic cultivation signifies a strategic endeavor to cultivate self-sufficiency within Germany’s cannabis market. While imports may continue to fulfill immediate demand, the issuance of cultivation licenses signals a broader commitment to fostering indigenous production capabilities. As stakeholders explore avenues for expanded cultivation initiatives, the industry braces for a period of innovation and expansion, poised to redefine Germany’s role within the global cannabis market.
Nevertheless, the timeline for achieving full autonomy in cannabis cultivation remains uncertain. While strides are made towards bolstering domestic production, Germany’s reliance on imports may persist in the short to medium term. As industry players navigate regulatory nuances and operational challenges, strategic partnerships and investments in cultivation infrastructure are poised to shape the trajectory of Germany’s cannabis industry, laying the groundwork for sustained growth and innovation.
Bottom Line
Germany’s record-breaking cannabis imports in 2023 underscore the nation’s pivotal role in shaping the global cannabis industry. Regulatory changes, such as the abolition of the cultivation quota system, signal a transformative shift towards self-sufficiency in domestic cultivation. While significant progress has been made, the timeline for achieving full autonomy remains uncertain. Strategic partnerships and investments will be instrumental in navigating regulatory complexities and ensuring sustainable growth in Germany’s evolving cannabis market.
HOW IS GERMANY IMPORTING WEED, READ ON…
Let’s imagine you just found out you have a surprise drug test at work and you “may or may not” need to flush THC out of your system as fast as possible by, say, Monday.
Detoxing from cannabis involves waiting until all traces of the substance have cleared the body, a process influenced by factors like usage frequency and quantity. If you need to flush all the weed out of your system within 10 days, order a Test Clear Kit here, they work well and have great customer reviews. But what is going on with your body and why does your body still have THC in it after smoking weed?
Cannabis comprises various compounds, notably tetrahydrocannabinol (THC) and cannabidiol (CBD). These substances bind to the same receptors as naturally occurring endocannabinoids, typically eliminated through urine and stool.
Detoxing from marijuana and managing cannabis use disorder involves a multifaceted approach. This includes goal setting with support, addressing withdrawal symptoms, managing physical and mental changes during detoxification, among other elements.
Given the individualized nature of substance use disorder, seeking professional addiction treatment is crucial. It allows for tailored detox strategies, managing potential side effects, handling marijuana overdose effects, and exploring diverse detox methodologies.
Understanding Marijuana Detox
Marijuana detox is the process of eliminating tetrahydrocannabinol (THC), marijuana’s psychoactive component, from the body. It is critical because THC can remain in the body’s fat cells even after marijuana usage has stopped, potentially resulting in positive drug test results or hampering efforts to achieve sobriety.
Marijuana detox is required to eliminate leftover THC from the system in those who are drug tested, such as sports, workers, or those in court. This protects against negative repercussions while also ensuring that testing protocols are followed.
The process of marijuana detox is essential to the goal of recovery. Removing THC from the body helps to terminate the cycle of reliance, lessen cravings, and make the road to recovery easier.
Additionally, persons suffering from marijuana-related health issues may require marijuana detox. Excessive or extended usage can be detrimental to both physical and mental health. Detoxification, which allows the body to rid itself of THC and its derivatives, may be able to mitigate any negative health consequences. Could you pass a THC drug test with 2 hours notice? Let’s find out…
What’s the duration of cannabis presence in the body?
As per American Addiction Centers, here’s the estimated duration for cannabis detection:
– Hair: Up to 90 days
– Urine: 3 days to over a month, contingent on usage
– Saliva: Approximately 48 hours
– Blood: Roughly 36 hours
Moreover, a 2017 study found that cannabinoids may persist in sweat for 7–14 days.
The duration of these compounds in one’s system varies widely. Another 2017 study highlights that the strain of cannabis used is a significant factor. Different strains contain varying cannabinoid levels, influencing their presence in the body.
Usage frequency also plays a role. Prolonged cannabis use prolongs cannabinoid traces in the body. This implies potential positive tests months after cessation; some have tested positive for THC even 3 months post-discontinuation.
Other factors impacting cannabis detection duration include:
– Consumption volume
– Exercise frequency and type
– Dietary habits
– Metabolic rate
– Body fat percentage
Given these variables, pinpointing the exact duration of cannabis, particularly THC, in one’s system after use can be challenging.
Optimal Methods for Weed Detox
Detoxifying from marijuana is multifaceted, with no singular “hack” to navigate through withdrawal, cravings, and other challenges.
Achieving the best results in marijuana detox entails considering various factors. Effective marijuana detox involves:
1. Attending to physical well-being by addressing common symptoms like aches and pains during withdrawal.
2. Maintaining a balanced diet with ample water intake, consistent healthy meals, and avoiding stimulants like caffeine.
3. Prioritizing mental health care to manage emotional adjustments in brain chemistry, such as anxiety or depression.
4. Implementing strategies to prevent relapse and cope with cravings through support groups, therapy, or treatment centers.
5. Engaging in therapeutic activities to foster new interests and habits, often facilitated through outpatient programs or professional assistance.
There’s no shortcut to hasten marijuana detox. However, practices like hydration, nutrition, warm showers, and exercise can aid in physical comfort. Yet, the body and mind still require time to purge THC remnants.
Rather than expediting detox, it’s crucial to utilize this period with medical guidance to establish a foundation for relapse prevention and address withdrawal symptoms.
Though treatments and medical detox programs exist, there’s no quick fix or magic remedy to instantly eliminate marijuana from the system or pass drug tests.
Symptoms like red eyes can be alleviated with cold compresses and eye drops.
Natural detoxification remains the most effective approach. The liver plays a pivotal role in removing marijuana and other toxins. Maintaining overall health supports liver function, aiding in toxin elimination and restoring bodily balance.
Various products claim to assist individuals in eliminating cannabis traces from their bodies, available in forms such as:
– Tablets
– Capsules
– Mouthwashes
– Shampoos
However, the effectiveness of these detoxes may vary depending on the type of drug test undergone. For instance, detoxes targeting urine cleansing might not yield desired results and could even result in a contaminated urine sample.
This occurs because urine-focused detoxes operate by purging the kidneys. While eliminating THC, they may inadvertently remove creatine and diminish urine’s natural density. Consequently, these factors could lead to the test appearing contaminated, necessitating a repeat test.
The Importance of Professional Marijuana Detox
Seeking marijuana detox with medical oversight is essential for safety and efficacy. Healthcare experts can craft personalized detox strategies tailored to an individual’s unique requirements, objectives, and medical background. They oversee the detox process, offer guidance, and manage any potential complications.
Supervised detox guarantees appropriate support and care, with healthcare professionals recommending additional treatments or therapies to address withdrawal symptoms and underlying issues contributing to marijuana usage.
Furthermore, medical supervision ensures the individual’s safety throughout detoxification. Abrupt cessation of marijuana may induce withdrawal symptoms, potentially uncomfortable or harmful. Professionals can employ measures to mitigate these symptoms and advise on managing cravings for sustained abstinence.
Bottom Line
THC detoxification is a complex process influenced by individual factors like usage patterns and metabolism. While natural methods offer effectiveness, seeking professional medical guidance ensures personalized care and safety. From managing withdrawal symptoms to addressing underlying issues, professional supervision enhances the detox journey. Remember, there’s no instant solution for THC detox, but with patience, proper care, and professional support, individuals can navigate towards sobriety and improved well-being successfully. By understanding the importance of medical supervision, individuals can embark on a journey of detoxification with confidence, knowing they have the necessary tools and support to achieve their goals.
PASS A DRUG TEST YOU HAD NO IDEA WAS COMING, READ ON…
Off To The Horse Races With Cannabis
The Future Of Cannabis After Rescheduling
A Happy Hippie’s Journey of Love, Cannabis, and Self-Discovery
But What about the UN Drug Treaties?
The Best Tips To Up Your Intimacy Game While High
What Can Consumers Expect From Marijuana Rescheduling
The Gilded Age Heiress Who Helped The Marijuana Movement
Tips For Your Body After Hours Of Sitting
Why Falling THC Test Results Matter
How Do You Get THC Out of Your System Fast?
Distressed Cannabis Business Takeaways – Canna Law Blog™
United States: Alex Malyshev And Melinda Fellner Discuss The Intersection Of Tax And Cannabis In New Video Series – Part VI: Licensing (Video)
Drug Testing for Marijuana – The Joint Blog
What you Need to Know
Cannabis, alcohol firm SNDL loses CA$372.4 million in 2022
NCIA Write About Their Equity Scholarship Program
City Of Oakland Issues RFP For Employee Training Programs
It has been a wild news week – here’s how CBD and weed can help you relax
A new April 20 cannabis contest includes a $40,000 purse
UArizona launches online cannabis compliance online course
-
Cannabis News1 year agoDistressed Cannabis Business Takeaways – Canna Law Blog™
-
One-Hit Wonders1 year agoUnited States: Alex Malyshev And Melinda Fellner Discuss The Intersection Of Tax And Cannabis In New Video Series – Part VI: Licensing (Video)
-
drug testing4 months agoDrug Testing for Marijuana – The Joint Blog
-
Cannabis 1011 year agoWhat you Need to Know
-
Marijuana Business Daily1 year agoCannabis, alcohol firm SNDL loses CA$372.4 million in 2022
-
Education1 year agoNCIA Write About Their Equity Scholarship Program
-
Education1 year agoCity Of Oakland Issues RFP For Employee Training Programs
-
Cannabis1 year agoIt has been a wild news week – here’s how CBD and weed can help you relax